Inicio › Cáncer (todos los tipos) › Nebraska
Ensayos clínicos de Cáncer (todos los tipos) en Nebraska
23 estudios sobre Cáncer (todos los tipos) buscan participantes en Nebraska.
Ciudades en Nebraska
Texto oficial del estudio (inglés)
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- NHO Revive Research Institute, LLC /ID# 267869, Lincoln
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 282497, Omaha
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT05650632RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Nebraska Medical Center, Omaha
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 10 nov 2026 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Nebraska Medicine-Bellevue, Bellevue
- CHI Health Saint Francis, Grand Island
- Fred and Pamela Buffett Cancer Center - Kearney, Kearney
- y 8 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT06580314Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Nebraska Cancer Specialists - Grand Island, Grand Island
- Nebraska Cancer Specialists, Omaha
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT04198766A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06901531Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
- Nebraska Cancer Specialists, Omaha
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07660055Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University Of Nebraska Medical Center, Omaha
ReclutandoFase 2/3
Todas las edades · Todos los sexos · Actualizado el 2 nov 2026 · NCT03435796Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Nebraska Cancer Specialist, Grand Island
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06162221A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Nebraska Medicine, Omaha
- Nebraska Medicine - Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06989437A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
- University of Nebraska Medical Center, Omaha
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07725796CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Fred and Pamela Buffett Cancer Center, Omaha
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT03328078A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- Mary Lanning Healthcare ( Site 0019), Hastings
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT06979596A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Nho - Revive Research Institute /ID# 276115, Lincoln
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07005102A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Nho - Revive Research Institute /ID# 277569, Lincoln
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07155187TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Nebraska Medical Center, Omaha
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT02693535Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Nebraska Cancer Specialists, Omaha
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06072612Project: Every Child for Younger Patients With Cancer
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
ReclutandoEstudio observacional
Hasta los 25 · Todos los sexos · Actualizado el 25 ago 2026 · NCT02402244Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Reclutando
Edades de 18 a 75 · Todos los sexos · Actualizado el 17 jun 2026 · NCT05486572GEMINI-NSCLC: NSCLC Biomarker Study
- Nebraska Cancer Specialists, Omaha
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 feb 2026 · NCT05236114SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Omaha
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
- University of Nebraska Medical Center, Omaha
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 may 2025 · NCT05970497Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Nebraska Cancer Specialists, Omaha
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 may 2025 · NCT05234177Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Nebraska Medicine - Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medicine, Omaha
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 nov 2024 · NCT03860883De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.